620 related articles for article (PubMed ID: 3010640)
1. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Franco-Cereceda A; Lundberg JM; Dahlöf C
Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
[TBL] [Abstract][Full Text] [Related]
3. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
Pernow J; Svenberg T; Lundberg JM
Eur J Pharmacol; 1987 Apr; 136(2):207-18. PubMed ID: 3595720
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
Dahlöf C; Dahlöf P; Tatemoto K; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):327-30. PubMed ID: 3838576
[TBL] [Abstract][Full Text] [Related]
5. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit.
Högestätt ED; Andersson KE; Edvinsson L
Acta Physiol Scand; 1982 Feb; 114(2):283-96. PubMed ID: 6127868
[TBL] [Abstract][Full Text] [Related]
6. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
7. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
Linton-Dahlöf P
Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
[TBL] [Abstract][Full Text] [Related]
8. Influence of extracellular calcium and nifedipine on alpha 1- and alpha 2-adrenoceptor-mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries.
Skärby T; Högestätt ED; Andersson KE
Acta Physiol Scand; 1985 Apr; 123(4):445-56. PubMed ID: 2859736
[TBL] [Abstract][Full Text] [Related]
9. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
Pernow J
Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
11. Cotransmission from sympathetic vasoconstrictor neurons: differences in guinea-pig mesenteric artery and vein.
Smyth L; Bobalova J; Ward SM; Keef KD; Mutafova-Yambolieva VN
Auton Neurosci; 2000 Dec; 86(1-2):18-29. PubMed ID: 11269921
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
13. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Donoso MV; Steiner M; Huidobro-Toro JP
J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y and sympathetic vascular control in man.
Lundberg JM; Torssell L; Sollevi A; Pernow J; Theodorsson Norheim E; Anggård A; Hamberger B
Regul Pept; 1985 Dec; 13(1):41-52. PubMed ID: 3841402
[TBL] [Abstract][Full Text] [Related]
15. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
16. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery.
Lundberg JM; Pernow J; Tatemoto K; Dahlöf C
Acta Physiol Scand; 1985 Apr; 123(4):511-3. PubMed ID: 3838851
[No Abstract] [Full Text] [Related]
17. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
18. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
Dietrich P; Moleda L; Kees F; Müller M; Straub RH; Hellerbrand C; Wiest R
J Hepatol; 2013 Feb; 58(2):254-61. PubMed ID: 23041305
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
Vu HQ; Budai D; Duckles SP
J Pharmacol Exp Ther; 1989 Dec; 251(3):852-7. PubMed ID: 2600818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
